Oklo Eyes $30 After 38% 2-Day Rally as $3.13B Cash Pile Offsets Aurora’s 2028–2029 Startup Slip

Oklo Inc. (NYSE:OKLO) traded at $26.58 at 12:37 p.m. ET on Monday, November 9, up $3.03, or 12.87%, from Friday’s close of $23.55. The stock opened at $23.74 and dipped to $22.73 in the first hour. It then climbed to an intraday high of $26.75, and by midday it was sitting 17 cents below that peak. Volume reached 8.81 million shares by midday, against a 10.04 million daily average. That puts the session on track to clear normal turnover well before the close. At $26.58, Oklo’s market value is about $5.19 billion on 195.29 million Class A shares.

Monday’s move builds on Friday’s reaction to third-quarter results. On Thursday, November 5, the stock closed at $19.20 after touching a 52-week low of $18.53 intraday. On Friday, November 6, it jumped 22.66% to $23.55 on volume of 24.87 million shares, more than double the average. Monday’s gain takes the rebound from Thursday’s close to 38.4% in two sessions, and the bounce from the $18.53 intraday low to 43.4%. The stock has not moved this hard on back-to-back sessions since the Meta-related surge at the start of the year.

The longer view still shows heavy damage. Oklo closed 2025 at $71.76, so it is down 62.96% in 2026 even after this rally. The 52-week high of $117.44 was set on November 10, 2025, which leaves the stock 77.4% below that peak. After the August 7 second-quarter report, shares closed at $48.42, and the slide from that level to Thursday’s $19.20 took 60.3% off the price in three months. The September and October sell-off came in a near-straight line. The stock lost its $40 handle on September 10, broke $30 on October 14 and fell below $25 on November 2.

Two forces drive the reversal. First, the third-quarter report removed the worst fear in the stock: that Oklo would have to raise its spending guidance again without matching progress. Guidance for 2026 operating cash use stayed at $120 million to $150 million, and property, plant and equipment spending stayed at $400 million to $500 million. Second, the whole power and nuclear group rallied hard on Monday. Constellation Energy rose 9.54%, NRG Energy 9.05%, Vistra 6.40%, NuScale Power 6.40% and NANO Nuclear Energy 10.75%. Oklo’s 12.87% gain sits at the top of that group, which fits a stock that had been sold harder than its peers into the report.

The question for the rest of November is whether $26.58 marks the start of a recovery or a relief rally inside a downtrend. The answer depends on cash burn, the pace of dilution and the Aurora schedule, and the third-quarter numbers give a clear read on all three.

The Third Quarter: $1.86 Million in Revenue Against a $71 Million Operating Loss

Oklo’s Form 10-Q for the quarter ended September 30, 2026 shows revenue of $1.861 million, up from $1.21 million in the first half of the year. That took nine-month revenue to $3.071 million. All of it came from ARMEC and Creative Engineers, the two engineering and manufacturing businesses Oklo bought on June 4 and June 15 for preliminary total consideration of $33.38 million. None of the revenue comes from power sales, fuel or isotopes. For now, the top line shows the acquired businesses at work rather than progress in Oklo’s core operations.

The cost side tells the real story. Loss from operations reached $71.0 million in the third quarter, almost double the $36.3 million operating loss in the same quarter of 2025. Research and development expenses rose $26.7 million year over year. Payroll and benefits added $9.9 million and stock-based compensation $4.1 million, as the R&D headcount rose by about 155 employees. Professional services for engineering consulting added another $8.3 million. General and administrative expenses grew $20.2 million, with payroll up $5.2 million, stock-based compensation up $6.0 million and 85 more administrative staff. For the nine months, the operating loss totals $195.2 million.

Net loss came in at $41.7 million, or $0.22 per Class A share, well below the operating loss. Two items closed the gap. Interest and dividend income on the cash pile reached about $27.9 million in the quarter, part of $72.4 million for nine months. Oklo also recognized an $11.43 million gain on a land sale to a third party. Without that one-off gain, the quarterly net loss would have been about $53.2 million, or roughly $0.27 per share. That matters because the $0.22 loss beat the $0.26 consensus, and the land sale accounts for the entire beat.

The year-to-date picture is clearer. Net loss for nine months stands at $123.3 million, or $0.69 per share, and trailing 12-month diluted loss per share is $0.96. Operating cash outflow over nine months was $110.9 million, of which $49.1 million was stock-based compensation. That puts Oklo on track to land inside its $120 million to $150 million operating cash-use range for the full year, provided the fourth quarter burns no more than about $39 million.

The quarter confirms that Oklo is a construction-stage company whose income statement is shaped by headcount growth and interest income, not by its business model. The market rewarded the absence of new bad news, not a change in the economics.

$3.13 Billion in Liquidity Puts the Stock at 1.66 Times Cash

The balance sheet carries the strongest argument for the stock at these prices. At September 30, Oklo held $1.550 billion in cash and cash equivalents and $1.581 billion in marketable debt securities. Of those securities, $951.8 million were current and $629.0 million noncurrent, bringing combined liquidity to $3.131 billion. A further $81.9 million sat in restricted cash. That included a $58.0 million letter of credit for an enriched uranium purchase, which was released on October 13. Liquidity rose from about $2.5 billion at the end of the first quarter and $3.0 billion at midyear.

Against 195.29 million shares outstanding on November 4, the $3.131 billion works out to $16.03 per share in cash and securities. At $26.58, the stock trades at 1.66 times that figure. The market is assigning about $10.55 per share, or roughly $2.06 billion in enterprise value, to everything else Oklo owns and plans. That includes the Aurora-INL powerhouse under construction, the Groves isotope reactors, the fuel fabrication facility, the Meta campus in Ohio, the acquired engineering businesses and the full development pipeline.

That gap shows how far sentiment had fallen. At the 52-week low of $18.53, the stock traded at just 1.16 times cash, and the market valued the entire operating business at about $490 million. Groves 1 alone cost roughly $75 million to build and fuel, and Aurora-INL has already absorbed a large part of $280.9 million in year-to-date capital spending. A valuation that low treated the company almost as a cash shell. Friday’s and Monday’s rally corrects part of that discount without making the stock expensive against its own balance sheet.

Management states that existing cash, cash equivalents and marketable securities will fund operations for at least one year after the financial statements were issued. With combined 2026 guidance for operating cash use and capex at $520 million to $650 million, the $3.131 billion covers roughly four and a half to six years of spending at this year’s rate. Spending will not stay at this year’s rate. Aurora construction, fuel fabrication and the Ohio campus all need more capital as they move from design into steel, and that is where the cash cushion meets the dilution question.

The cash pile buys time, and time is what a pre-revenue nuclear developer needs most. It does not answer what Aurora will cost per megawatt, and that number is still missing.

Dilution Is the Price of the Cash Pile

Oklo built that liquidity by selling shares into the open market through at-the-market programs. In the first half of 2026, it issued 23.09 million shares for about $1.85 billion in net proceeds, at an average gross sale price of $81.44. In the third quarter, it issued another 9.52 million shares for about $401.8 million, an average of roughly $42.21 per share. Net cash from common stock sales totalled $2.254 billion over the nine months. On September 11, the company set up a new at-the-market program for up to $1 billion in additional shares.

The share count shows the result. Oklo had 195.16 million shares issued at September 30 and 195.29 million by November 4. The 32.6 million shares sold this year represent about 16.7% of the current count. Each new share has been sold at a lower price than the last batch. Shares sold in the first half averaged $81.44. Shares sold in the third quarter averaged about $42.21. At $26.58, any further issuance would come at roughly a third of the first-half average.

The pricing matters because it changes the cost of capital. At $81.44, Oklo raised about $1 million for every 12,300 shares it sold. At $26.58, raising the same amount would need about 37,600 shares, three times as many. The company could raise $500 million at today’s price by issuing about 18.8 million shares, around 9.6% of the current count. A $1 billion raise would take 37.6 million shares, close to a fifth of the company. That math is why the stock’s slide fed on itself through September and October. Every leg lower raised the dilution cost of the next raise.

The third-quarter cash flow also showed how quickly new capital is being used. Roughly $400 million of stock issued in the quarter added only about $100 million to liquidity, because capital spending of about $154 million and operating cash use absorbed the rest. Year-to-date capex reached $280.9 million at September 30, against $126.9 million at midyear. Spending has moved from planning into construction, and it now consumes most of what each raise brings in.

For shareholders, Monday’s rally helps. A higher price reduces the number of shares Oklo must sell to fund 2027. As long as $3.131 billion sits on the balance sheet, the company has no need to issue stock at $26 rather than waiting for a better price. The risk is a renewed slide that coincides with a funding need. Oklo then faces the choice it faced in October: accept heavy dilution or slow construction.

Capex Climbs to $280.9 Million and 2026 Guidance Holds at $400 Million to $500 Million

The most important number in the report was the one that did not change. Oklo reaffirmed 2026 guidance for operating cash use of $120 million to $150 million and for property, plant and equipment spending of $400 million to $500 million. Both ranges were raised at the second-quarter report in August. Operating cash use went from $80 million to $100 million, and capex from $350 million to $450 million. The market had braced for a second increase without matching progress. It did not happen, and that is the main reason the stock rallied 22.66% on Friday.

Holding the guidance comes with a heavy fourth quarter. Year-to-date capex stands at $280.9 million, so Oklo must spend between $119.1 million and $219.1 million in the final three months to land inside the range. The midpoint of $450 million implies about $169 million in the fourth quarter, slightly above the third quarter’s roughly $154 million. That fits a project moving from excavation into vertical construction, where spending on steel, components and equipment speeds up. If fourth-quarter capex comes in below $119 million, the shortfall would point to delays rather than savings.

Operating cash use follows the same logic. At $110.9 million for nine months, Oklo needs $9.1 million to $39.1 million more in the fourth quarter to land inside its range. The third-quarter run rate was well above the bottom of that band, so the full-year number will likely come in at the upper half. Stock-based compensation, which made up $49.1 million of nine-month cash use, inflates the total. Excluding it, the underlying cash cost of the business is lower than the headline figure suggests.

Management laid out 2027 milestones without giving a 2027 spending range. A3F is to produce its first full fuel assembly. The recycling pilot facility is to be commissioned. Major reactor components are to be installed at Aurora. Groves 2 construction is to start and the first contracted isotope delivery is to be completed. Every one of those milestones requires more spending than in 2026. A reasonable base case puts 2027 combined operating cash use and capex above this year’s $520 million to $650 million. That would still leave more than $2 billion in liquidity at the end of 2027 without new raises.

The guidance hold gave the stock breathing room, but the key question has only moved back a quarter. The full-year 2026 report in March will show whether spending stays inside the range. It will also bring the first 2027 guidance, and investors will compare that number directly against the $3.131 billion cash cushion.

Aurora-INL Moves Into Vertical Steel as the Startup Window Widens to 2028–2029

Construction at the Aurora powerhouse at Idaho National Laboratory has moved into a new phase. Excavation of the reactor area is complete. Structural and safety-related rebar work is underway, and vertical steel was going up by November 4. Component requests for proposals are out, vendors have been selected, and the focus is shifting to fabrication, delivery and integration. Kiewit Nuclear Solutions is the lead constructor. For a project that was a cleared site 14 months ago, the physical progress is real.

The schedule is less firm. The 10-Q now describes Aurora’s startup window as 2028 to 2029. Management had held to a firm 2028 target from the fourth quarter of 2025 through the second quarter of 2026. On the call, CEO Jake DeWitte did not confirm a date. He pointed to commissioning and instrumentation as among the longest-lead items, citing lessons from Groves, and said the company is building in schedule buffer. The market read the shift as a modest slip rather than a reset, and the stock’s rally suggests it had priced worse.

The regulatory path is clearer than the schedule. The Department of Energy has approved the preliminary documented safety analysis for Aurora-INL, a key step under the DOE authorization route Oklo chose instead of a traditional Nuclear Regulatory Commission construction licence. The remaining steps are completion and approval of the full documented safety analysis, a readiness review and startup authorization. DeWitte said the documented safety analysis will come closer to construction completion, not before 2028. Under DOE authorization, Aurora may sell power to national laboratories and others before transitioning to an NRC licence. It may also sell irradiation services and isotopes.

Cost remains the biggest gap. Oklo has still not disclosed a total cost for Aurora-INL or a capital cost per megawatt. Management deferred the figure across several calls, each time pointing to later in 2026, and the third-quarter call again gave no number. Without it, investors cannot judge whether Aurora’s economics will support a fleet. A low number would turn the plant into a reference design that customers can underwrite. A high one would raise doubts about the whole pipeline. Either way, the absence of the figure leaves a valuation discount in the stock.

Aurora is a 75-megawatt-class fast reactor using metallic fuel and liquid-metal cooling, a design family the US has not operated commercially since EBR-II shut down. That is both the opportunity and the risk. A working first unit would put Oklo ahead of most small reactor developers. A delay beyond 2029 would push first revenue from power sales well into the next decade and stretch the cash runway.

Groves 1 Gave the Market Its First Hard Cost Benchmark

The Groves Isotope Test Reactor in Texas gave Oklo its biggest operational win of the year. The Department of Energy authorized startup on July 23, and Groves reached first criticality on August 5. Construction took 229 days, and first criticality came a little over 11 months after groundbreaking. Groves was built on private land with private capital. It was the first reactor in the DOE’s Reactor Pilot Program to reach criticality on privately owned land. The program had set a July 4 deadline, which Oklo missed by about a month.

On the third-quarter call, management disclosed what Groves cost. The build cost was about $65 million, plus about $10 million for fuel purchased from Framatome, roughly $75 million in total. That is the first hard cost figure Oklo has given for any reactor it has built. Groves is a low-power isotope test reactor, not a power plant, so the figure does not translate directly into Aurora’s economics. It does show that Oklo can design, permit, build and start a nuclear reactor in under a year for a known budget. That is a rare record in an industry known for overruns.

Groves 2 is the next step. It is planned as an integrated isotope facility covering irradiation, processing and product finishing. The DOE selected it for the Nuclear Energy Launch Pad, and Oklo has already bought fuel from Framatome. Site location and final scope are still being set, and no cost has been disclosed. Management targets the start of Groves 2 construction in 2027, alongside the first contracted isotope delivery, which was previously expected in 2026 or early 2027.

The isotope business matters for valuation because it can produce revenue before Aurora does. Isotopes serve specialized markets in healthcare and space, where small volumes command high prices. Oklo’s isotope segment came from its 2025 acquisition of Atomic Alchemy. Groves 1 is expected to produce research and development quantities of isotopes within about a year of criticality, and commercial revenue would follow from Groves 2 and the Idaho radiochemistry laboratory. The slip in the first contracted delivery to 2027 removes a near-term revenue catalyst. It also pushes the point where Oklo’s revenue reflects its own technology further out.

Groves explains much of the stock’s behaviour this year. Criticality on August 5 lifted the shares to $48.42 on August 7, the high-water mark of the second half. The market then sold the stock 60.3% lower over three months, as investors moved from celebrating the milestone to asking what Aurora would cost. The $75 million figure partly answers that question. It gives the market a benchmark for Oklo’s construction discipline.

The 27-Module Forging Deal Signals Fleet Ambitions

Alongside its results, Oklo announced a capacity agreement with U.S. Forged Rings. The deal reserves capacity for large reactor components, including vessels, lids and support structures, equivalent to 27 Aurora modules over 2030 to 2035. Oklo is making an initial small investment in USFR, with the amount undisclosed. Deliveries depend on USFR completing and qualifying its planned US manufacturing campus. That is a real dependency, because heavy forgings are one of the tightest bottlenecks in the nuclear supply chain.

The deal says more about Oklo’s ambitions than about near-term revenue. Twenty-seven modules is a fleet-scale commitment. If each module is a 75-megawatt-class unit, the reserved capacity would cover roughly 2 gigawatts over six years. Management did not confirm that figure when it was raised on the call. Oklo has not yet signed a binding power purchase agreement for a single commercial Aurora unit. Reserving forgings for 27 shows management expects demand to arrive faster than the supply chain can respond, and wants a place in the queue before competitors fill it.

Securing domestic forging capacity also reduces a key strategic risk. Large nuclear forgings have historically come from a short list of overseas suppliers, mainly in Japan, South Korea and France. Lead times can run for years and are exposed to trade and geopolitical disruption. A US source for Aurora’s heaviest parts shortens the chain and fits the federal push to rebuild the domestic nuclear industrial base. It also helps with cost control, because forgings are among the most expensive single items in any reactor build.

The timing matches the rest of the plan. Aurora-INL starts up in 2028 to 2029. The Ohio campus for Meta follows. The forging deal covers 2030 to 2035, the period in which Oklo expects to move from one-off builds to repeat production. If Aurora works and its costs land where management needs them to, those forgings become the backbone of a fleet. If Aurora slips or its economics disappoint, the commitment will be easy to scale back, given the small initial investment.

The market treated the announcement as a confidence signal and pushed the stock 22.66% higher on Friday. That reaction makes sense in the context of a stock that had lost 60% in three months. The deal shows management planning for scale at a time when the stock price implied investors doubted Oklo would get past its first plant. It does not change near-term cash flow, and it does not resolve the cost question at Aurora-INL.

Meta’s Ohio Campus and the PJM Bottleneck

Oklo’s largest commercial relationship is with Meta Platforms. Under their agreement, Oklo plans a power campus of up to 1.2 gigawatts on 206 acres in Pike County, Ohio, to supply Meta’s data centres in the region. Meta has included a prepayment mechanism that gives Oklo upfront capital to secure fuel and advance early development. Equinix is also a customer with payments already received. These relationships carry the bull case. They show hyperscale computing companies are willing to pay in advance for future nuclear capacity.

The third-quarter call clarified how far that commitment reaches. DeWitte said the Meta agreement does not bind either party to build the reactors. CFO Craig Bealmear said the deal does include binding elements, including Meta’s capital that secures reservation capacity, and that the first milestone is securing fuel. Oklo has not disclosed the prepayment amount. Meta’s money is real and supports development spending, but it is not yet a construction contract or a power purchase agreement. Until one of those is signed, the Ohio campus remains a development project rather than booked revenue.

Grid access is the second constraint. Oklo has 900 megawatts under active consideration in PJM’s 2026 cluster study. PJM is the grid operator covering Ohio, Virginia and much of the Mid-Atlantic. PJM withdrew one of Oklo’s Virginia applications, and the Federal Energy Regulatory Commission dismissed Oklo’s complaint over that withdrawal. Oklo disputes PJM’s technical reasons. Management says the Ohio application is unaffected, and Bealmear expects the PJM process to take about 24 months.

That timeline matters for the share price. A 24-month interconnection review running from 2026 means Ohio’s grid connection would clear around late 2028. That is close to the Aurora-INL startup window, so the two projects would overlap. Oklo cannot sell power from Ohio until both the reactors are built and the grid connection is approved. Any delay at PJM would push the Meta revenue stream out even if construction goes smoothly. The Virginia withdrawal shows grid operators are not fast-tracking advanced reactor applications, whatever the political support for nuclear power.

The Meta relationship is still the single most valuable asset in Oklo’s pipeline. A hyperscaler with deep resources that prepays for capacity gives Oklo both funding and credibility. The path from agreement to revenue now runs through three gates: fuel supply, PJM interconnection and a binding contract. Converting the Meta deal into a firm power purchase agreement would be the single biggest catalyst the stock could get before Aurora starts up.

Fuel Is the Quiet Constraint: A3F, EBR-II and Plutonium

Fuel is where advanced reactor projects most often stall. Aurora needs high-assay low-enriched uranium in metallic form, a fuel the commercial market barely supplies. Oklo is tackling the problem on several fronts. The Aurora Fuel Fabrication Facility at Idaho National Laboratory, known as A3F, is installing equipment. The first full fuel assembly is targeted for 2027, timed to match Aurora’s startup. For the first core, Oklo has secured access to recovered fuel from the Experimental Breeder Reactor-II, the government fast reactor that ran at the same Idaho site until 1994.

EBR-II material removes the first-core supply risk but cannot fuel a fleet. For later reactors, Oklo is pursuing enrichment partnerships and recycling used nuclear fuel through its planned Advanced Fuel Center in Oak Ridge, Tennessee. It is also seeking surplus government plutonium. On the call, DeWitte said timing for the government surplus material should become clearer in the next few months. He added that the material is expected to come without a specific fee, with the recipient bearing fabrication costs. Access to plutonium would give Oklo a large, low-cost feedstock outside the commercial uranium market.

Recycling is the long-term piece. Oklo targets commissioning its recycling pilot facility in 2027. The Department of Energy’s Nuclear Lifecycle Innovation Campus initiative could support the business by helping solve fuel infrastructure problems. Management also cited the Nuclear Waste Fund, which held more than $50 billion at the end of fiscal 2025, as a potential source of support for recycling. Any access to that fund would need action from Congress. For now it is a policy possibility, not a funding line.

Oklo is also developing third-party fuel fabrication and technical services as a new revenue stream. DeWitte said some early services revenue could arrive within about two years, with the main ramp coming after the facilities scale into operation. The focus is fuel enriched above 5% and just under 20%, the range most advanced reactor designs need. No dollar figures were given. If it works, the fuel business would bring in revenue from other reactor developers well before Oklo’s own fleet is built.

The fuel strategy is one of Oklo’s real differentiators. Many small reactor developers depend on a HALEU supply chain that does not yet exist at scale. Oklo has a first core secured, a fabrication plant under construction and several routes to later supply. The risk is concentration in timing. A3F, the recycling pilot, Groves 2 and Aurora component installation all fall in 2027. A slip in any one of them would affect the others.

Policy Tailwinds From the NRC and DOE

Federal policy has rarely been this supportive of advanced nuclear power, and Oklo is positioned to benefit. The Nuclear Regulatory Commission has finalized a rule letting applicants use technical evidence from DOE-authorized projects in commercial licensing. In practice, data from Aurora-INL, built and operated under DOE oversight, can support Oklo’s later NRC licence applications for commercial units. That shortens a process that has historically taken years and cost hundreds of millions of dollars per design.

The DOE authorization route is the core of Oklo’s strategy. Oklo moved Aurora-INL out of the NRC combined licence process and into the DOE Reactor Pilot Program in 2025. That let construction start years before an NRC licence would have allowed it. The trade-off is that DOE-authorized plants face limits on commercial operation. Management said Aurora may still sell power to national labs and other buyers, along with irradiation services and isotopes, before transitioning to an NRC licence. The new NRC rule makes that transition more efficient.

The Nuclear Energy Launch Pad programme, which selected Groves 2, adds another federal channel. So does the Nuclear Lifecycle Innovation Campus initiative, which DeWitte described as a significant opportunity for the recycling business. Earlier policy moves, including DOE approval of the A3F fuel facility under the Advanced Nuclear Fuel Line Pilot Projects, set the pattern. The federal government is creating faster pathways specifically for companies that bring private capital and are willing to build first.

Policy support has limits. Grid operators like PJM are not bound by federal nuclear enthusiasm, as the Virginia withdrawal shows. Access to the Nuclear Waste Fund requires Congress. Surplus plutonium allocations depend on DOE decisions whose timing Oklo does not control. Federal policy can also shift with administrations and budgets. A company whose path to market relies on DOE authorization is exposed to any change in that framework, even if bipartisan support for nuclear power looks durable for now.

For the stock, policy acts as a floor under the long-term story rather than a near-term driver. It reduces the chance that Oklo’s projects stall in licensing. It does not resolve the cost of Aurora, the pace of dilution or the conversion of Meta’s agreement into a binding contract. Those company-specific questions decide where the stock trades in the next six months. Policy decides whether the company exists in a decade. The NRC rule is the most valuable regulatory change of the quarter, because it links Oklo’s DOE-backed head start directly to its commercial fleet plans.

Monday’s Rally Lifted the Whole Nuclear and Power Complex

Oklo did not rally alone on Monday. Independent power producers and nuclear developers moved together. Constellation Energy, the largest US nuclear operator, rose 9.54% to $273.80. NRG Energy gained 9.05% to $96.28, Vistra 6.40% to $132.78 and Talen Energy 6.14% to $359.42. Among small reactor developers, NANO Nuclear Energy climbed 10.75% to $12.31 and NuScale Power 6.40% to $5.41. Geothermal developer Fervo Energy added 23.38% to $11.14. The move was broad across power generation, not limited to nuclear names.

Oklo’s 12.87% gain led the established nuclear group, and the reason is positioning. Before the report, the stock had fallen further than its peers. From its 2025 close, Oklo was down 73.2% at Thursday’s $19.20 close. That made it the most heavily shorted and most oversold name in the group. When the whole sector rallies, the stock with the most short positions and the deepest discount to cash tends to move most. Friday’s earnings reaction set up Monday’s follow-through.

The sector rally came on a day when Nvidia fell 4.73% to $177.81. That split matters for Oklo, which trades as a proxy for AI power demand. Investors bought the companies that supply electricity to data centres while selling the leading chip maker. That rotation fits a view that power availability, not chips, is the binding constraint on AI growth. Oklo’s pitch to Meta and Equinix rests on exactly that view. When the market leans that way, Oklo benefits regardless of its own news.

The relative valuations explain how much risk sits in Oklo compared with its peers. Constellation, Vistra, Talen and NRG all run operating plants that generate cash today. Oklo has no power revenue and will not have any until at least 2028. NuScale, its nearest listed peer among small reactor developers, trades at $5.41 after a 26% fall in a single week. That shows how quickly sentiment can turn against pre-revenue nuclear names. Oklo’s cash position of $16.03 per share gives it more downside protection than most of those peers.

Sector momentum supports Oklo in the near term but makes it vulnerable to any turn in the AI power trade. If Nvidia’s weakness spreads into a broader retreat from AI-related names, the power complex would likely give back part of Monday’s gains, and Oklo would fall further than the operators. If capital keeps rotating from chips into power, Oklo is the highest-beta way to own that move.

Technical Map: $26.75 Resistance, the $30 Gate and the $18.53 Floor

The first resistance level for Oklo is Monday’s intraday high of $26.75, just 17 cents above the current price. A close above $26.75 would confirm the breakout from Friday’s $20.86–$24.03 range. The next level is $27.12 to $27.33, where the stock closed on October 27 and 28. Above that sits $27.97, the October 16 close, and then $30.01, the October 15 close. The $30 level is where the September–October slide gathered pace, so it is the gate that matters for any recovery.

A move from $26.58 to $30 would be a further 12.9% gain. That would put the stock 56.3% above Thursday’s $19.20 close and 1.87 times cash per share. Above $30, the next zones are $34.57 to $34.70, the October 8 and 9 closes, and then $36.14 to $38.55, the early-October range. A return to $40, last seen on September 22 at $40.45, would require a 50.5% rally from current levels. That would almost certainly need a hard Aurora cost figure or a binding Meta contract.

Momentum favours the upside in the short term. The stock has made two large gains in a row, closing Friday near the top of its range and trading near Monday’s high at midday. Friday’s volume of 24.87 million shares was 2.5 times the 10.04 million average, a sign of real buying rather than a thin short squeeze. Even after this rally, the price sits well below its 200-day moving average in the low $50s. That marks the bigger trend as still bearish. Rebounds this sharp after deep sell-offs often retrace part of the gain before the next move.

On the downside, the first support is Friday’s close at $23.55, followed by Monday’s opening level of $23.74 and the $22.73 intraday low. A close below $22.73 would give back most of Monday’s gain. The next level is $22.12, the November 4 close, and then $19.20, Thursday’s close. The 52-week low of $18.53 is the floor. A break below it would put the stock close to its $16.03 cash value per share, and the market would be pricing the operating business at almost nothing.

The pattern to watch over the next week is whether the stock holds above $23.55 on any pullback. Holding that level would confirm that buyers are absorbing selling after two strong days. A drop back below $22.73 would mean the rebound was a short-covering bounce inside the downtrend. For traders, a daily close above $26.75 targets $30. A close below $23.55 shifts attention back to the $19.20 to $18.53 zone.

Event Risk, Valuation Balance and the Verdict on OKLO

Oklo’s scheduled catalysts are now spread out, which leaves the stock trading on sector flows and company news in the coming weeks. The most likely near-term news includes plutonium allocation, which management said should become clearer within months, and any progress on converting the Meta agreement into a binding contract. Other items to watch are further DOE steps on Aurora-INL, PJM interconnection updates for Ohio and new fuel or supply-chain agreements. The full-year 2026 report in March will show whether capex landed inside $400 million to $500 million and will set 2027 guidance.

The valuation balance now leans toward buyers. At $26.58, the stock trades at 1.66 times its $16.03 per share in cash and securities. That values the operating business at about $2.06 billion, including Aurora-INL, Groves, A3F, the isotope business, the Meta campus pipeline and the acquired engineering firms. At the 52-week low of $18.53, that figure was about $490 million. The two-day rally has repaired part of the discount, but the stock still trades far below the $117.44 high of November 2025 and the $71.76 level where it started 2026.

The bear case is clear and has not gone away. Aurora’s startup window has widened to 2028–2029. Its total cost is still undisclosed. Meta’s agreement does not bind either side to build the reactors. PJM rejected a Virginia application and expects the Ohio review to take about 24 months. The third-quarter operating loss doubled to $71.0 million, and the $0.22 per-share loss benefited from an $11.43 million one-off land sale gain. The share count has grown 16.7% this year through at-the-market sales. At $26.58, every further dollar raised costs three times as many shares as the first-half issuance did.

The bull case rests on execution and the balance sheet. Groves reached criticality in 229 days of construction for roughly $75 million. Vertical steel is going up at Aurora-INL. DOE approved the preliminary documented safety analysis, and the NRC finalized a rule letting DOE project data feed into commercial licensing. The forging deal reserves capacity for 27 Aurora modules. Liquidity of $3.131 billion covers years of spending at the current rate, and 2026 guidance held without a second increase.

The verdict on Oklo is speculative buy from $26.58, with tight risk control. A daily close above Monday’s $26.75 high targets $30 in the coming weeks and $34.57 to $34.70 on any Meta contract news or a disclosed Aurora cost figure that the market can underwrite. Friday’s $23.55 close is the line that defines the trade. A close below it cancels the near-term upside and puts the $19.20 to $18.53 zone back in play. A break of $18.53 opens a move toward the $16.03 cash floor. The stock suits investors who accept that a 50% move in either direction is possible within months. Oklo’s $3.131 billion balance sheet limits how low the stock can fall. The undisclosed cost of Aurora decides how high it can rise.

That's TradingNEWS